MedPath
FDA Approval

Creon

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 27, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pancrelipase lipase(12000 [USP'U] in 1 1)
Pancrelipase amylase(60000 [USP'U] in 1 1)
Pancrelipase protease(38000 [USP'U] in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Atlantic Biologicals Corps

047437707

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Atlantic Biologicals Corps

Atlantic Biologicals Corps

Atlantic Biologicals Corps

047437707

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Creon

Product Details

NDC Product Code
17856-1212
Application Number
NDA020725
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 27, 2012
Code: 8MYC33932OClass: ACTIBQuantity: 12000 [USP'U] in 1 1
cetyl alcoholInactive
Code: 936JST6JCNClass: IACT
Code: YOJ58O116EClass: ACTIBQuantity: 60000 [USP'U] in 1 1
hypromellosesInactive
Code: 3NXW29V3WOClass: IACT
Code: 3560D81V50Class: ACTIBQuantity: 38000 [USP'U] in 1 1
dimethiconeInactive
Code: 92RU3N3Y1OClass: IACT
POLYETHYLENE GLYCOLSInactive
Code: 3WJQ0SDW1AClass: IACT
triethyl citrateInactive
Code: 8Z96QXD6UMClass: IACT
© Copyright 2025. All Rights Reserved by MedPath